HBK Investments’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-15,000
Closed -$182K 945
2019
Q1
$182K Buy
+15,000
New +$187K ﹤0.01% 979
2018
Q1
Sell
-5,694
Closed -$213K 1107
2017
Q4
$213K Buy
+5,694
New +$290K ﹤0.01% 916
2016
Q1
Sell
-16,600
Closed -$1.13M 1086
2015
Q4
$1.13M Buy
16,600
+6,400
+63% +$386K 0.01% 539
2015
Q3
$462K Sell
10,200
-9,000
-47% -$524K ﹤0.01% 767
2015
Q2
$1.01M Buy
+19,200
New +$758K 0.01% 558
2014
Q3
Sell
-16,695
Closed -$376K 1050
2014
Q2
$376K Sell
16,695
-5,605
-25% -$140K 0.01% 750
2014
Q1
$854K Buy
+22,300
New +$719K 0.02% 535

Other funds holding PRTA

HBK Investments's PRTA Position: Q2 2019 in Review

HBK Investments sold out of Prothena Corp (PRTA) in Q2 2019, closing a stake of 15,000 shares — an estimated $182K sold.

HBK Investments first reported a position in PRTA in Q1 2014 and held it in 7 quarters. The position peaked at $1.13M in Q4 2015. 138 funds tracked by Wall St. Rank hold PRTA as of Q2 2019.

  • HBK Investments reported no remaining Prothena Corp position as of Q2 2019 after selling out during the quarter.
  • HBK Investments sold 15,000 Prothena Corp shares in Q2 2019, an estimated $182K.
  • HBK Investments first reported a position in Prothena Corp in Q1 2014 and held it in 7 quarters.
  • HBK Investments's Prothena Corp position peaked at $1.13M in Q4 2015.
  • 138 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2019.

Based on HBK Investments's 13F filing for Q2 2019, filed 14 Aug 2019.